[Federal Register Volume 81, Number 2 (Tuesday, January 5, 2016)]
[Notices]
[Page 242]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-33171]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2015-N-0001]
Advisory Committee; Food Advisory Committee, Renewal
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice; renewal of advisory committee.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing the
renewal of the Food Advisory Committee by the Commissioner of Food and
Drugs (the Commissioner). The Commissioner has determined that it is in
the public interest to renew the Food Advisory Committee for an
additional 2 years beyond the charter expiration date. The new charter
will be in effect until the December 18, 2017.
DATES: Authority for the Food Advisory Committee will expire on
December 18, 2017, unless the Commissioner formally determines that
renewal is in the public interest.
FOR FURTHER INFORMATION CONTACT: Karen Strambler, Center for Food
Safety and Applied Nutrition, Office of Regulations, Policy, and Social
Sciences, Food and Drug Administration, 5100 Paint Branch Pkwy.,
College Park, MD 20740, 240-402-2589, [email protected].
SUPPLEMENTARY INFORMATION: Pursuant to 41 CFR 102-3.65 and approval by
the Department of Health and Human Services pursuant to 45 CFR part 11
and by the General Services Administration, FDA is announcing the
renewal of the Food Advisory Committee. The committee is a
discretionary Federal advisory committee established to provide advice
to the Commissioner.
I. Objectives and Scope of Activities
The Food Advisory Committee (the Committee) advises the
Commissioner or designee in discharging responsibilities as they relate
to helping to ensure safe and effective drugs for human use and, as
required, any other product for which FDA has regulatory
responsibility.
II. Description of Duties
The Committee reviews and evaluates emerging food safety,
nutrition, and other food- or cosmetic-related health issues that FDA
considers of primary importance for its food and cosmetics programs.
The Committee may be charged with reviewing and evaluating available
data and making recommendations on matters such as those relating to:
(1) Broad scientific and technical food- or cosmetic-related issues;
(2) the safety of food ingredients and new foods; (3) labeling of foods
and cosmetics; (4) nutrient needs and nutritional adequacy; and (5)
safe exposure limits for food contaminants. The Committee may also be
asked to provide advice and make recommendations on ways of
communicating to the public the potential risks associated with these
issues and on approaches that might be considered for addressing the
issues.
III. Membership and Designation
The Committee shall consist of a core of 15 voting members
including the Chair. Members and the Chair are selected by the
Commissioner or designee from among authorities knowledgeable in the
fields of physical sciences, biological and life sciences, food
science, risk assessment, nutrition, food technology, molecular
biology, epidemiology, and other relevant scientific and technical
disciplines. Members will be invited to serve for overlapping terms of
up to 4 years. Almost all non-Federal members of this committee serve
as Special Government Employees. The core of voting members may include
two technically qualified member(s), selected by the Commissioner or
designee, who are identified with consumer interests and are
recommended by either a consortium of consumer-oriented organizations
or other interested persons. In addition to the voting members, the
Committee may include two non-voting member(s) who are identified with
industry interests.
Further information regarding the most recent charter and other
information can be found at http://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/FoodAdvisoryCommittee/ucm120646.htm or by
contacting the Designated Federal Officer (see FOR FURTHER INFORMATION
CONTACT). In light of the fact that no change has been made to the
committee name or description of duties, no amendment will be made to
21 CFR 14.100.
This document is issued under the Federal Advisory Committee Act (5
U.S.C. app.). For general information related to FDA advisory
committees, please visit us at http://www.fda.gov/AdvisoryCommittees/default.htm.
Dated: December 30, 2015.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2015-33171 Filed 1-4-16; 8:45 am]
BILLING CODE 4164-01-P